Drug Shortage Report for TEVA-TOBRAMYCIN
Report ID | 10911 |
Drug Identification Number | 02389622 |
Brand name | TEVA-TOBRAMYCIN |
Common or Proper name | TOBRAMYCIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 60MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 5 |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-29 |
Estimated end date | 2018-07-06 |
Actual end date | 2018-07-12 |
Shortage status | Resolved |
Updated date | 2018-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-05-23 | English | Compare |
v2 | 2017-05-23 | French | Compare |
v3 | 2017-09-19 | English | Compare |
v4 | 2017-09-19 | French | Compare |
v5 | 2018-01-03 | English | Compare |
v6 | 2018-01-03 | French | Compare |
v7 | 2018-03-13 | English | Compare |
v8 | 2018-03-13 | French | Compare |
v9 | 2018-07-30 | English | Compare |
v10 | 2018-07-30 | French | Compare |
Showing 1 to 10 of 10